Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81774003, 81773868)
This publication has 34 references indexed in Scilit:
- Targeted therapy: An elusive cancer targetNature, 2016
- Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparumNature Communications, 2015
- Constitutive activation of STAT3 in breast cancer cells: A reviewInternational Journal of Cancer, 2015
- Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cellsCancer Letters, 2015
- STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast CancerStem Cells, 2014
- Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor BurdenFrontiers in Oncology, 2014
- Induction of epithelial–mesenchymal transition (EMT) in breast cancer cells is calcium signal dependentOncogene, 2013
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumorsJournal of Clinical Investigation, 2011
- Breast cancer stem cells: treatment resistance and therapeutic opportunitiesCarcinogenesis, 2011
- Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6Science, 1994